Mostrando 2 resultados de: 2
Subtipo de publicación
Article(2)
Área temáticas
Enfermedades(2)
Microorganismos, hongos y algas(2)
Medicina forense; incidencia de enfermedades(1)
Año de Publicación
2021(2)
Origen
scopus(2)
COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing
ArticleAbstract: Background: Lateral flow device (LFD) viral antigen immunoassays have been developed around the worlPalabras claves:CORONAVIRUS, covid-19, Lateral flow, Lateral flow tests, Lateralflow devices, LFD, National evaluation, PUBLIC HEALTH, SARS-COV-2, TESTING, United Kingdom, VIral antigen detectionAutores:Affron D., Afrough B., Agasu A., Ainsworth M., Allanson A., Allen C., Allen K., Archer L., Ashbridge N., Aurfan I., Avery M., Badenoch E., Bagga P., Balaji R., Baldwin E., Barraclough S., Beane C., Bell J., Benford T., Bird S., Bishop M., Bloss A., Body R., Boulton R., Bown A., Bratten C., Bridgeman C., Britton D., Brooks T.J.G., Broughton-Smith M., Brown P., Buck B., Butcher E., Byrne W., Calderon G., Campbell S., Carr O., Carter D.P., Carter P., Cathrall M., Catton M., Chadwick J., Chapman D., Chau K.K., Chaudary T., Chidavaenzi S., Chilcott S., Choi B., Christopher H. Logue, Claasen H., Clark S., Clarke D., Clarke R., Clayton R., Collins K., Colston R., Connolly J., Cook E., Corcoran M., Corley B., Costello L., Coulson C., Crook A., Crook D.W., D'Arcangelo S., Darby M.A., Davis J., de Koning R., Derbyshire P., Devall P., Dolman M., Draper N., Driver M., Dyas S., Eaton E., Edwards J., Elderfield R., Ellis G., Ellis K., Elwell S., Evans B., Evans M., Evans R., Eyre D.W., Fahey C., Fenech V., Field A., Field J., Foord T., Fowler T., French M., Fuchs H., Gan J., Gernon J., Ghadiali G., Ghuman N., Gibbons K., Gill G., Gilmour K., Peto T.Fuentes:scopusLongitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease
ArticleAbstract: The kinetics of the immune changes in COVID-19 across severity groups have not been rigorously assesPalabras claves:bystander CD8+ T cell, complement, covid-19, immune pathology, INTERFERÓN, recovery, SARS-COV-2, Systemic inflammation, TNF-αAutores:Allison J., Ansaripour A., Baker S., Bergamaschi L., Betancourt A., Bong S.H., Bower G., Bradley J.R., Bucke A., Bullman B., Bunclark K., Butcher H., Calder J., Calero-Nieto F.J., Canna L., Caputo D., Clapham-Riley D., Cossetti C., Coudert J.D., de Bie E.M.D.D., de Sa A., Dewhurst E., di Stefano G., Doffinger R., Domingo J., Dougan G., Dunmore B.J., Elmer A., Emma Jones, Epping M., Fahey C., Fawke S., Fuller S., Furlong A., Gerber P.P., Gleadall N., Goodfellow I.G., Göttgens B., Graf S., Graves B., Gray J., Grenfell R., Gupta R.K., Hanson A.L., Harris J., Hess C., Hewitt S., Hinch A., Hodgson J., Holmes E., Hosmillo M., Huang C., Huhn O., Hunter K., Ivers T., Jackson S., Jarvis I., Jose S., Josipovic M., Kasanicki M., Kennet J., Kingston N., Kotagiri P., Kourampa J., Laurenti E., Le Gresley E., Legchenko E., Lehner P.J., Lewis D., Linger R., Lyons P.A., Mackay M., Marioni J.C., Marsden J., Martin J., Matara C., Matheson N.J., Meadows A., Meloy S., Mende N., Mescia F., Michael A., Michel R., Morgan M.D., Muldoon F., Mwaura L., Nice F., Nicholson J.K., Petrunkina A.M., Richardson S., Ruffieux H., Saunders C., Smith K.G.C., Thaventhiran J.E.D., Toonen E.J.M., Toshner M., Turner L., Weekes M.P., Wills M.R.Fuentes:scopus